Results 261 to 270 of about 213,470 (338)

A New Era in Obesity Treatment: The Evolution of Antiobesity Medications (AOMs) Based on Clinical Trials. [PDF]

J Diabetes
Liu D, Chen Y.
europepmc   +1 more source

MCV/Q, Medical College of Virginia Quarterly, Vol. 13 No. 1 [PDF]

, 1977

core   +1 more source

Astrocyte Lipid Droplet Dynamics Orchestrate Neurological Disorders and Therapeutic Horizons

Small Science, EarlyView.
This review examines astrocyte lipid droplet (LD) metabolism in neurological disorders, including Alzheimer's disease, stroke, epilepsy, and glioma. It analyzes regulatory mechanisms governing LD formation, transport, and degradation in astrocytes, highlighting their potential as biomarkers and therapeutic targets through integrative multiomics ...
Jiani Zhong, Yanyi Peng, Lingyue Zhang, Bo Xiao, Mengqi Zhang   +4 more
wiley   +1 more source

Survodutide: a novel peptide for treatment of obesity and metabolic diseases. [PDF]

Proc (Bayl Univ Med Cent)
Vinton TY.
europepmc   +1 more source

Effects of glucagon and insulin on cytoplasmic protein phosphorylation in hepatocytes

, 1978
Joseph Avruch, Lee A. Witters, M.C. Alexander, Michael A. Bush   +3 more
openalex   +1 more source

Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers

Small Methods, EarlyView.
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz, Nima Pourafzal, Audrey T. Zhu, Zhongyuan Guo, Ronnie H. Fang, Liangfang Zhang   +5 more
wiley   +1 more source

Glucagon-like peptide 1 (GLP-1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials. [PDF]

Diabetes Obes Metab
Parker CH, Slattery C, Brennan DJ, le Roux CW.   +3 more
europepmc   +1 more source

Differences in the Fecal Metabolome of Autoimmune Pancreatitis Patients

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.
Vladyslav Dovhalyuk, Fan Yang, Sara Nikolic, Miroslav Vujasinovic, J.‐Matthias Löhr, Daniel Globisch   +5 more
wiley   +1 more source

Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance. [PDF]

Nat Commun
Kobayashi N, Okazaki Y, Iwane A, Hara K, Horikoshi M, Awazawa M, Soeda K, Matsushita M, Sasako T, Yoshimura K, Itoh N, Kobayashi K, Seto Y, Yamauchi T, Aburatani H, Blüher M, Kadowaki T, Ueki K.   +17 more
europepmc   +1 more source